The use of mechanical insufflation-exsufflation in invasively ventilated critically ill adults: a scoping review protocol.


Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
08 12 2020
Historique:
received: 15 07 2020
accepted: 26 11 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 25 6 2021
Statut: epublish

Résumé

Critically ill patients receiving invasive ventilation are at risk of sputum retention. Mechanical insufflation-exsufflation (MI-E) is a technique used to mobilise sputum and optimise airway clearance. Recently, interest has increased in the use of mechanical insufflation-exsufflation for invasively ventilated critically ill adults, but evidence for the feasibility, safety and efficacy of this treatment is sparse. The aim of this scoping review is to map current and emerging evidence on the feasibility, safety and efficacy of MI-E for invasively ventilated adult patients with the aim of highlighting knowledge gaps and identifying areas for future research. Specific research questions aim to identify information informing indications and contraindications to the use of MI-E in the invasively ventilated adult, MI-E settings used, outcome measures reported within studies, adverse effects reported and perceived barriers and facilitators to using MI-E reported. We will search electronic databases MEDLINE, EMBASE, CINAHL using the OVID platform, PROSPERO, The Cochrane Library, ISI Web of Science and the International Clinical Trials Registry Platform. Two authors will independently screen citations, extract data and evaluate risk of bias using the Mixed Methods Appraisal Tool. Studies included will present original data and describe MI-E in invasively ventilated adult patients from 1990 onwards. Our exclusion criteria are studies in a paediatric population, editorial pieces or letters and animal or bench studies. Search results will be presented in a PRISMA study flow diagram. Descriptive statistics will be used to summarise quantitative data. For qualitative data relating to barriers and facilitators, we will use content analysis and the Theoretical Domains Framework (TDF) as a conceptual framework. Additional tables and relevant figures will present data addressing our research questions. Our findings will enable us to map current and emerging evidence on the feasibility, safety and efficacy of MI-E for invasively ventilated critically ill adult patients. These data will provide description of how the technique is currently used, support healthcare professionals in their clinical decision making and highlight areas for future research in this important clinical area. Open Science Framework submitted on 9 July 2020.  https://osf.io/mpksq/ .

Sections du résumé

BACKGROUND
Critically ill patients receiving invasive ventilation are at risk of sputum retention. Mechanical insufflation-exsufflation (MI-E) is a technique used to mobilise sputum and optimise airway clearance. Recently, interest has increased in the use of mechanical insufflation-exsufflation for invasively ventilated critically ill adults, but evidence for the feasibility, safety and efficacy of this treatment is sparse. The aim of this scoping review is to map current and emerging evidence on the feasibility, safety and efficacy of MI-E for invasively ventilated adult patients with the aim of highlighting knowledge gaps and identifying areas for future research. Specific research questions aim to identify information informing indications and contraindications to the use of MI-E in the invasively ventilated adult, MI-E settings used, outcome measures reported within studies, adverse effects reported and perceived barriers and facilitators to using MI-E reported.
METHODS
We will search electronic databases MEDLINE, EMBASE, CINAHL using the OVID platform, PROSPERO, The Cochrane Library, ISI Web of Science and the International Clinical Trials Registry Platform. Two authors will independently screen citations, extract data and evaluate risk of bias using the Mixed Methods Appraisal Tool. Studies included will present original data and describe MI-E in invasively ventilated adult patients from 1990 onwards. Our exclusion criteria are studies in a paediatric population, editorial pieces or letters and animal or bench studies. Search results will be presented in a PRISMA study flow diagram. Descriptive statistics will be used to summarise quantitative data. For qualitative data relating to barriers and facilitators, we will use content analysis and the Theoretical Domains Framework (TDF) as a conceptual framework. Additional tables and relevant figures will present data addressing our research questions.
DISCUSSION
Our findings will enable us to map current and emerging evidence on the feasibility, safety and efficacy of MI-E for invasively ventilated critically ill adult patients. These data will provide description of how the technique is currently used, support healthcare professionals in their clinical decision making and highlight areas for future research in this important clinical area.
SYSTEMATIC REVIEW REGISTRATION
Open Science Framework submitted on 9 July 2020.  https://osf.io/mpksq/ .

Identifiants

pubmed: 33292485
doi: 10.1186/s13643-020-01547-8
pii: 10.1186/s13643-020-01547-8
pmc: PMC7724723
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

287

Subventions

Organisme : Department of Health
ID : NIHR300504
Pays : United Kingdom

Références

Chest. 2005 Oct;128(4):2772-7
pubmed: 16236954
N Engl J Med. 2010 Dec 2;363(23):2233-47
pubmed: 21121836
Curr Opin Crit Care. 2003 Feb;9(1):59-66
pubmed: 12548031
Int J Nurs Stud. 2012 Jan;49(1):47-53
pubmed: 21835406
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
BMC Med Res Methodol. 2016 Feb 09;16:15
pubmed: 26857112
Cochrane Database Syst Rev. 2017 Jan 11;1:CD011833
pubmed: 28075489
Am J Crit Care. 2015 Jul;24(4):318-24; quiz 325
pubmed: 26134331
Clin Nurs Res. 2019 May 14;:1054773819846024
pubmed: 31088144
Respir Care. 2011 Aug;56(8):1217-9
pubmed: 21801584
Chest. 2006 Jan;129(1 Suppl):48S-53S
pubmed: 16428691
Chest. 1993 Nov;104(5):1553-62
pubmed: 8222823
Respir Care. 2017 Feb;62(2):236-245
pubmed: 28108686
Respir Care. 2016 Oct;61(10):1360-8
pubmed: 27624630
Respir Care. 2018 Dec;63(12):1506-1513
pubmed: 30206128
Respir Med. 2018 Mar;136:98-110
pubmed: 29501255
Respir Care. 2018 Dec;63(12):1471-1477
pubmed: 30018175
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986

Auteurs

Ema Swingwood (E)

Faculty of Health and Social Care, University of the West of England, Bristol, UK. ema.swingwood@uhbristol.nhs.uk.
Adult Therapy Services A804, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Upper Maudlin Street, Bristol, BS2 8HW, UK. ema.swingwood@uhbristol.nhs.uk.

Willemke Stilma (W)

Faculty of Health, Center of Expertise Urban Vitality, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands. w.stilma@amsterdamumc.nl.
Department of Intensive Care Medicine, Amsterdam University Medical Centers, location 'AMC', Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. w.stilma@amsterdamumc.nl.

Lyvonne Tume (L)

School of Health and Society, University of Salford, Manchester, UK.
Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Fiona Cramp (F)

Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK.

Frederique Paulus (F)

Faculty of Health, Center of Expertise Urban Vitality, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands.
Department of Intensive Care Medicine, Amsterdam University Medical Centers, location 'AMC', Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.

Marcus Schultz (M)

Department of Intensive Care Medicine, Amsterdam University Medical Centers, location 'AMC', Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.
Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam University Medical Centers, location 'AMC', Amsterdam, the Netherlands.
Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Wilma Scholte Op Reimer (W)

Department of Cardiology, Amsterdam University Medical Centers, location 'AMC', Amsterdam, the Netherlands.

Louise Rose (L)

Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
Lane Fox Respiratory Unit, Guy's and Thomas' Foundation NHS Hospital Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH